NTRK2 and in situ carcinoma: We examined involvement of BDNF/TrkB signaling in CIS-induced exacerbated mechanical allodynia by administering TrkB specific antagonist CTX-B (20 mg/kg, intraperitoneal, once/day for 8 days).